In January 2022 Ecraid became a legal entity and is now fully operational to advance knowledge in the field of infectious diseases.
Partnering for the development of sustainable clinical research infrastructures and a skilled workforce in Africa - Convened by EDCTP/ECRIN
ECRIN has engaged in a strategic bilateral partnership with EUPATI, the European Patients’ Academy on Therapeutic Innovation.
Medical device development, from conception to timely release to market, can be expensive and risky. This is particularly true for high-risk medical devices affected by the EU’s current Regulation 2017/745.
This policy brief, entitled ” Scaling-Up Research Projects Through ERICs: Impact of Big Science on The Research Ecosystem” showcases the pivotal role of Research Infrastructures (RIs) and ERICs in particular in the European research development and innovation ecos
The International Rare Diseases Research Consortium (IRDiRC) is proud to announce the publication of a commentary on 10 years of progress and challenges of IRDiRC in the prestigious journal Nature Reviews Drug Discovery.
The Joint Access Advisory Mechanism (JAAM) is the entryway for the European COVID-19 adaptive platform trials (APTs).
On January 19th, the ECRAID Prime project held its official kick-off meeting online. This ambitious project aims to establish a network for the implementation of an early phase platform trial for COVID-19 treatments in the primary care setting.
F-CRIN, ECRIN’s French national scientific partner, certified 4 new research and investigation networks on pathologies of national interest:
On 17 January 2022 RI-VIS held its Final Meeting. The meeting celebrated the numerous accomplishments carried out by the project over the last 3 years.
New publication: Biomarker discovery studies for patient stratification using machine learning analysis of omics data: a scoping review
The PERMIT project aims to share its findings at every stage. A first publication has been issued from the series of scoping reviews that were performed during the first year of the project.
On 3 December 2021 EMA and ECRIN offered a joint training session to the ECRIN CTU community, Implementation of the Clinical Trial Regulation (EU) No 536/2014 for academia: Live demonstration of CTIS and Q&A session.
After its initial certification last year by the French Association for St
Developing a vaccine is a time-consuming and complex process, requiring a combination of specialized skills and technical capacities not readily available at a single organization.
The EULAC PerMed December newsletter is now out. In this edition you will find information on upcoming webinars, the ERA PerMed: Joint Transnational Call 2022 on Prevention in Personalised Medicine, and the ICPerMed Best Practice in Personalised Medicine Recognition 2021.
On 26 November 2021 ECRIN hosted its first CTU Day bringing together members of its CTU community from all 12 of its national networks.
The EU-Africa PerMed project just released its first newsletter. Through this first newsletter you can learn about the project, results of the scientific and policy mapping exercise and events both past and upcoming.